Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
03/20/2013 | CN102973904A Drug for treatment and postoperative care of uterus myoma |
03/20/2013 | CN102973896A Traditional Chinese medicine composition for treating tumor |
03/20/2013 | CN102973893A Traditional Chinese medicine combination for treating cancers |
03/20/2013 | CN102973892A Traditional Chinese medicine combination for treating breast cancer |
03/20/2013 | CN102973830A Method for extracting flavonoid from asparagus |
03/20/2013 | CN102973826A Chinese laxative drug for removing fire factor |
03/20/2013 | CN102973808A Medicament for treating cancer |
03/20/2013 | CN102973805A Traditional Chinese medicine composition for treating esophagus cancer |
03/20/2013 | CN102973751A Antineoplastic agent |
03/20/2013 | CN102973749A Preparation method and applications of divaricate saposhnikovia-angelica archang lica rhinitis tablets |
03/20/2013 | CN102973735A Traditional Chinese medicine used for treating hysteromyoma |
03/20/2013 | CN102973677A Traditional Chinese medicine for treating ovarian cyst |
03/20/2013 | CN102973667A Preparation method and application of cold-fever tablet |
03/20/2013 | CN102973636A Common threewingnut root microemlusion-based gel preparation and preparation method thereof |
03/20/2013 | CN102973623A Separation method of ginseng rare saponins in ginseng fibrils |
03/20/2013 | CN102973616A High-bioactivity ganoderma spore oil and supercritical preparation method thereof |
03/20/2013 | CN102973605A Toad skin extract dry powder inhalant and preparation method and applications thereof |
03/20/2013 | CN102973604A Toad skin extract dry powder inhalant and preparation method and applications thereof |
03/20/2013 | CN102973573A Human breast cancer cell inhibitor and preparation method thereof |
03/20/2013 | CN102973572A Cervical cancer cell inhibitor and preparation method thereof |
03/20/2013 | CN102973550A Pharmaceutical composition for inhibiting cancer stem cell growth or cancer cell metastasis by using wogonin, and application thereof |
03/20/2013 | CN102973549A Drug composition |
03/20/2013 | CN102973528A Calcitriol solid lipidic dispersion and preparation method thereof |
03/20/2013 | CN102973525A Antharcycline antitumor antibiotics loaded nano-micelle preparation and preparation method thereof |
03/20/2013 | CN102973513A Intelligent nano-medicament delivery system and preparation method and application thereof |
03/20/2013 | CN102973512A Adriamycin-loaded albumin nano-particle preparation with folate receptor targeting function and preparation method thereof |
03/20/2013 | CN102973510A Method for preparing dual-function targeting quantum dot lipidosome |
03/20/2013 | CN102973503A Norcantharidin derivative lipid microsphere injection and preparation method thereof |
03/20/2013 | CN102973491A Nanoscale docetaxel and preparation method thereof |
03/20/2013 | CN102973490A Nanoscale docetaxel and preparation method thereof |
03/20/2013 | CN102973488A Nano-hydrogel with oxidation-reduction/pH double-stimulation responsiveness and preparation method and application thereof |
03/20/2013 | CN102579360B Preparation method of 5-fluorouracil-carried pH-sensitive drug-bearing microsphere |
03/20/2013 | CN102552185B 9-nitrocamptothecin mixed micelle freeze-dried powder injection and preparation method thereof |
03/20/2013 | CN102525964B Gemcitabine hydrochloride lyophilized powder injection |
03/20/2013 | CN102363019B Curcuma zedoary oil extract, preparation method thereof and purpose thereof |
03/20/2013 | CN102351848B Rotenone cyclopropanecarboxamide and its preparation method and use |
03/20/2013 | CN102335368B Decoction for treating cerebroma and application thereof |
03/20/2013 | CN102327275B Application of 3-[4-(sulfonyl)benzene] urea compound in preparation of medicine for tumour |
03/20/2013 | CN102319290B Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma |
03/20/2013 | CN102304128B Heterocyclic naphthalimide derivative as well as preparation method and application thereof |
03/20/2013 | CN102232943B Antrodia camphorata cyclohexenone compound for inhibiting skin cancer tumor cell growth |
03/20/2013 | CN102178847B Vacuum freeze-drying processing method of dendrobium officinale |
03/20/2013 | CN102160868B Application of astragaloside IV in preparing liver cancer resisting medicines |
03/20/2013 | CN102145062B Active extracts of rosa roxburghii tratt fruit, and preparation method, detection method and application thereof |
03/20/2013 | CN102126933B Diphenyl propane lignan compound and preparation method thereof |
03/20/2013 | CN102125574B Medicinal composition for suppressing tumors |
03/20/2013 | CN102101888B Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof |
03/20/2013 | CN102070556B 5-benzyl-4-alkyl-2-aminothiazole as well as preparation and application of 5-benzyl-4-alkyl-2-aminothiazole |
03/20/2013 | CN102065865B Multiple myeloma treatments |
03/20/2013 | CN102060793B Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof |
03/20/2013 | CN102058836B Medicament composition with effects of resisting thrombus, reducing blood pressure and treating leukemia |
03/20/2013 | CN101991590B Stilbene glucoside medical composition and preparation method thereof |
03/20/2013 | CN101928335B Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof |
03/20/2013 | CN101917982B Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents |
03/20/2013 | CN101899051B 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof |
03/20/2013 | CN101856368B Crocodile choline, preparation method and application thereof |
03/20/2013 | CN101843653B Processing method of Chinese stellera root condensed decoction |
03/20/2013 | CN101838307B K2 polypeptide synthesis product and application thereof |
03/20/2013 | CN101838306B K4 polypeptide synthesis product and application thereof |
03/20/2013 | CN101735196B Method for synthesizing Imatinib |
03/20/2013 | CN101677978B Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
03/20/2013 | CN101669936B Drug combination containing pratensein and application thereof in drugs |
03/20/2013 | CN101648865B Polyphenol acrylic acid derivative and application thereof in medicaments |
03/20/2013 | CN101624360B Substituted organic sulfur compound and application thereof |
03/20/2013 | CN101619305B Antihuman CD52 monoclonal antibody hybridoma cell line, monoclonal antibody, engineered antibody, carrier, reagent kit and application thereof |
03/20/2013 | CN101583357B Use of MTOR antagonist and angiogenesis inhibitor for preparing medicine for treating cancer |
03/20/2013 | CN101538305B Method for preparing composite with antineoplastic activity by panoxadiol |
03/20/2013 | CN101530589B Chinese medicinal preparation for treating cancers |
03/20/2013 | CN101530464B Alcohol extract of walnut kernel and use thereof |
03/20/2013 | CN101485665B Novel medical use of cucurbitacin |
03/20/2013 | CN101475596B Platinum complexes of quercetin and derivatives thereof, as well as preparation and use thereof |
03/20/2013 | CN101474186B 2,3,4,7,8-polysubstituted naphthyridine [4,3-d] pyridine derivates with anti-tumor activity |
03/20/2013 | CN101439017B Method for preparing polymer aqueous solution formulation of taxane anti-tumor medicament |
03/20/2013 | CN101390831B Docetaxel medical composition for injection and preparation method thereof |
03/20/2013 | CN101247837B Novel salts of conjugated psychotropic drugs and processes of preparing same |
03/20/2013 | CN101243043B Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
03/20/2013 | CN101237771B Multidrug resistant anticancer anthracyclines |
03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
03/19/2013 | US8399617 Non-functional P2X7 receptor |
03/19/2013 | US8399520 Selective estrogen receptor modulator |
03/19/2013 | US8399479 Modulators of cystic fibrosis transmembrane conductance regulator |
03/19/2013 | US8399477 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
03/19/2013 | US8399449 Fused heterocyclic derivative and use thereof |
03/19/2013 | US8399435 Compounds for the treatment of proliferative disorders |
03/19/2013 | US8399431 Cyclodextrin-based polymers for therapeutics delivery |
03/19/2013 | US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same |
03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
03/19/2013 | US8398980 Subtypes of humanized antibody against interleuken-6 receptor |
03/19/2013 | CA2733445C Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use |
03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
03/19/2013 | CA2660799C Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
03/19/2013 | CA2576191C T type calcium channel inhibitors |
03/19/2013 | CA2556227C Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
03/19/2013 | CA2513251C Cancer therapy sensitizer |
03/19/2013 | CA2491907C Oncolytic virus replicating selectively in tumor cells |
03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
03/19/2013 | CA2440303C Wt1 modified peptide |
03/19/2013 | CA2435363C New inhibitors against galectins |
03/19/2013 | CA2429342C Promoters exhibiting endothelial cell specificity and methods of using same |
03/19/2013 | CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |